Shigella flexneri Castellani and Chalmers (ATCC® 25876)

Strain Designations: Mel SmD  /  Type Strain: no  /  Biosafety Level: 2

Strain Designations Mel SmD
Application
Used to produce oral vaccine in Yugoslavia
Enteric Research
Emerging infectious disease research
Isolation
Streptomycin-dependent clone derived from Shigella flexneri (Serotype 2a) ATCC 25875
Biosafety Level 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Antigenic Properties Serotype 2a
Product Format freeze-dried
Preceptrol® no
Type Strain no
Antigenic Properties Serotype 2a
Medium ATCC® Medium 55: Nutrient agar with dihydrostreptomycin 625 mcg/ml
Growth Conditions
Temperature: 37.0°C
Name of Depositor O Felsenfeld
Chain of Custody
ATCC <<--O Felsenfeld<<--D. Mel
Isolation
Streptomycin-dependent clone derived from Shigella flexneri (Serotype 2a) ATCC 25875
References

Mel DM, et al. Studies on vaccination against bacillary dysentery. 1. Immunization of mice against experimental Shigella infection. Bull. World Health Organ. 32: 633-636, 1965. PubMed: 5294178